Location: Palo Alto, CA
CIK: 0001306923 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value: $1.147B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2,061,373 | $171M | 14.9% | $83.16 | -4.3% | COM | 09061G101 |
| UTHR | UNITED THERAPEUTICS CORP | 634,806 | $150M | 13.0% | $89.23 | +127.8% | COM | 91307C102 |
| — | ABIOMED INC | 494,397 | $122M | 10.7% | $81.43 | — | COM | 003654100 |
| INSM | INSMED INC | 5,840,398 | $115M | 10.0% | $17.79 | +17.8% | COM | 457669307 |
| FOLD | AMICUS THERAPEUTICS INC | 9,847,774 | $106M | 9.2% | $9.52 | -13.5% | COM | 03152W109 |
| STAA | STAAR SURGICAL CO | 1,106,567 | $78.49M | 6.8% | $14.28 | +351.3% | COM | 852312305 |
| BIIB | BIOGEN INC | 360,981 | $73.62M | 6.4% | $264.06 | -22.6% | COM | 09062X103 |
| — | REVANCE THERAPEUTICS INC | 4,405,039 | $60.88M | 5.3% | $21.99 | — | COM | 761330109 |
| PRTA | PROTHENA CORP PLC | 1,681,477 | $45.65M | 4.0% | $21.46 | +36.3% | COM | G72800108 |
| — | SAGE THERAPEUTICS INC | 851,409 | $27.5M | 2.4% | $46.62 | — | COM | 78667J108 |
| VNDA | VANDA PHARMACEUTICALS INC | 2,491,200 | $27.15M | 2.4% | $11.21 | -7.6% | COM | 921659108 |
| — | KARYOPHARM THERAPEUTICS INC | 5,621,533 | $25.35M | 2.2% | $16.36 | — | COM | 48576U106 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,678,196 | $23.65M | 2.1% | $33.89 | -44.9% | COM | 004225108 |
| ALKS | ALKERMES PLC | 603,400 | $17.98M | 1.6% | $22.36 | +28.5% | COM | G01767105 |
| EHTH | EHEALTH INC | 1,654,693 | $15.44M | 1.3% | $59.40 | -82.9% | COM | 28238P109 |
| GOSS | GOSSAMER BIO INC | 1,750,651 | $14.65M | 1.3% | $11.85 | -34.6% | COM | 38341P102 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 612,600 | $11.79M | 1.0% | $16.84 | -1.1% | COM | 87164F105 |
| ALGN | ALIGN TECHNOLOGY INC | 44,305 | $10.49M | 0.9% | $114.31 | +168.8% | COM | 016255101 |
| — | EPIZYME INC | 6,774,541 | $9.959M | 0.9% | $11.87 | — | COM | 29428V104 |
| ANAB | ANAPTYSBIO INC | 431,024 | $8.75M | 0.8% | $19.06 | +16.2% | COM | 032724106 |
| — | CLOVIS ONCOLOGY INC | 4,473,967 | $8.053M | 0.7% | $42.71 | — | COM | 189464100 |
| — | GRITSTONE ONCOLOGY INC | 2,330,504 | $5.64M | 0.5% | $9.42 | — | COM | 39868T105 |
| — | KEZAR LIFE SCIENCES INC | 656,200 | $5.427M | 0.5% | $5.16 | — | COM | 49372L100 |
| CYTK | CYTOKINETICS INC | 111,717 | $4.389M | 0.4% | $6.71 | +499.7% | COM | 23282W605 |
| TVTX | TRAVERE THERAPEUTICS INC | 166,069 | $4.024M | 0.4% | $23.56 | +6.8% | COM | 89422G107 |
| MIRM | MIRUM PHARMACEUTICALS INC | 64,700 | $1.259M | 0.1% | $15.56 | +51.6% | COM | 604749101 |
| — | ALIMERA SCIENCES INC | 200,919 | $1.099M | 0.1% | $6.30 | — | COM | 016259202 |
| NVAX | NOVAVAX INC | 12,500 | $643K | 0.1% | $171.82 | -69.9% | COM | 670002401 |
| ALDX | ALDEYRA THERAPEUTICS INC | 160,800 | $642K | 0.1% | $7.10 | -51.5% | COM | 01438T106 |
| — | MAGENTA THERAPEUTICS INC | 432,300 | $519K | 0.0% | $7.38 | — | COM | 55910K108 |
| URGN | UROGEN PHARMA LTD | 24,500 | $201K | 0.0% | $27.01 | -74.6% | COM | M96088105 |
| TCMD | TACTILE SYSTEMS TECHNOLOGY I | 27,100 | $198K | 0.0% | $39.74 | -68.1% | COM | 87357P100 |
| — | MARINUS PHARMACEUTICALS INC | 31,330 | $152K | 0.0% | $15.48 | — | COM | 56854Q200 |